ANSAID TABLETS 100 MG 100 MG — DIN 00600792
FLURBIPROFEN : 100 MG · PFIZER CANADA ULC · TABLET · wholesale supply in Canada
Health Canada status: CANCELLED POST MARKET
What is ANSAID TABLETS 100 MG?
ANSAID TABLETS 100 MG 100 MG contains FLURBIPROFEN : 100 MG. It is listed in the Health Canada Drug Product Database under DIN 00600792, held by PFIZER CANADA ULC, supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 25-Jul-2013. This Drug Identification Number is no longer authorized for sale in Canada, so Nexara does not supply it. The record is kept here because buyers still meet the number on old formularies, purchase orders and tender documents; Nexara can help identify an authorized alternative.
What is ANSAID TABLETS 100 MG used for?
Relief of signs and symptoms of rheumatoid arthritis, osteoarthritis and ankylosing spondylitis; relief of pain associated with dysmenorrhoea; relief of mild to moderate pain with inflammation.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
How much does Flurbiprofen cost around the world?
Flurbiprofen is listed on 5 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Bahrain publishes a retail (max); Greece publishes a producer price (ex-factory); Saudi Arabia publishes a public. Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| South Africa | single exit price | 4 | 5 | ZAR███.██ |
| Saudi Arabia | public | 2 | 4 | SAR███.██ |
| United States | acquisition | 2 | 2 | USD███.██ |
| Bahrain | retail (max) | 1 | 1 | BHD███.██ |
| Greece | producer price (ex-factory) | 1 | 1 | EUR███.██ |
13 pack listings across 10 brand entries and 5 price bases, refreshed 03 Sep 2026. Ranges span every Flurbiprofen pack in that market, so a high figure is usually a larger pack rather than the same product.
This table is a regulatory record of where the molecule is listed. The DIN on this page is no longer authorized for sale in Canada, so Nexara does not quote it — see the alternatives above.
Is there a generic Flurbiprofen in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
9 holders have a Canadian DIN containing Flurbiprofen, across 19 DINs, of which 2 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| AA PHARMA INC | 2 | 2 | FLURBIPROFEN | Sourceable in Canada |
| ABBOTT LABORATORIES, LIMITED | 3 | 0 | FROBEN, FROBEN SR | No marketed DIN |
| ORGANON CANADA LTD LTEE | 3 | 0 | FROBEN TAB 100MG, FROBEN TAB 50MG, FROBEN-SR CAP 200MG | No marketed DIN |
| NU-PHARM INC | 2 | 0 | NU-FLURBIPROFEN TAB 100MG, NU-FLURBIPROFEN TAB 50MG | No marketed DIN |
| PFIZER CANADA ULC | 2 | 0 | ANSAID TABLETS 100 MG, ANSAID TABLETS 50 MG | No marketed DIN |
| PRO DOC LIMITEE | 2 | 0 | FLURBIPROFEN-100 TAB 100MG, FLURBIPROFEN-50 TAB 50MG | No marketed DIN |
| RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED | 2 | 0 | RATIO-FLURBIPROFEN TABLETS 100MG, RATIO-FLURBIPROFEN TABLETS 50MG | No marketed DIN |
| TEVA CANADA LIMITED | 2 | 0 | TEVA-FLURBIPROFEN | No marketed DIN |
| NOVOPHARM LIMITED | 1 | 0 | NOVO-FLURPROFEN SR | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 100 MG |
|---|---|
| Dosage form | TABLET |
| Route | ORAL |
| Pack configuration (monograph) | 50 mg and 100 mg tablets. (Specific container types like bottles not detailed in provided text summary). |
| Storage | Store at 15-30°C (Standard USP range, though specific text was truncated, summary table implies standard handling). |
Pack detail is kept as a regulatory record. This DIN is no longer authorized for sale in Canada, so Nexara does not quote this pack.
Substance and classification
| Active substance | Flurbiprofen |
|---|---|
| ATC code | M01AE09 |
| AHFS class | 28:08.04.92 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 00600792 |
|---|---|
| DIN (unpadded, as printed on some documents) | 600792 |
| Brand name | ANSAID TABLETS 100 MG |
| Generic / active ingredient | FLURBIPROFEN : 100 MG |
| Market authorization holder | PFIZER CANADA ULC |
| Health Canada schedule | Prescription |
| ATC code | M01AE09 |
| ATC anatomical main group | M — Musculo-skeletal system |
| ATC therapeutic subgroup | M01AE |
| Current status | CANCELLED POST MARKET |
| Status date | 25-Jul-2013 |
| Original market date | 1985-12-31 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
How is it administered?
Use lowest effective dose for shortest duration. For OA/RA: 200-300 mg/day in 2-4 divided doses. Dysmenorrhoea: 50 mg q6h. Mild-moderate pain: 50 mg q6h. Max 300 mg/day.
Included because it drives pack selection and wastage. Consult the monograph.
Contraindications
CABG surgery peri-operative setting; 3rd trimester pregnancy; breastfeeding; severe heart failure; hypersensitivity to flurbiprofen/NSAIDs; ASA-intolerance; active GI ulcer/bleeding; severe liver/renal impairment.
Warnings and precautions
Risk of serious cardiovascular (MI, stroke) and gastrointestinal (ulcer, perforation, bleed) events. May cause hypertension, fluid retention, and serious skin reactions (SJS/TEN).
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
2 of 19 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| FLURBIPROFEN | 100 MG | TABLET | AA PHARMA INC | MARKETED | 01912038 |
| FLURBIPROFEN | 50 MG | TABLET | AA PHARMA INC | MARKETED | 01912046 |
| ANSAID TABLETS 50 MG | 50 MG | TABLET | PFIZER CANADA ULC | CANCELLED POST MARKET | 00647942 |
| FLURBIPROFEN-100 TAB 100MG | 100 MG | TABLET | PRO DOC LIMITEE | CANCELLED POST MARKET | 01947737 |
| FLURBIPROFEN-50 TAB 50MG | 50 MG | TABLET | PRO DOC LIMITEE | CANCELLED POST MARKET | 01947729 |
| FROBEN | 50 MG | TABLET | ABBOTT LABORATORIES, LIMITED | CANCELLED POST MARKET | 02223066 |
| FROBEN | 100 MG | TABLET | ABBOTT LABORATORIES, LIMITED | CANCELLED POST MARKET | 02223074 |
| FROBEN SR | 200 MG | CAPSULE (SUSTAINED-RELEASE) | ABBOTT LABORATORIES, LIMITED | CANCELLED POST MARKET | 02223082 |
| FROBEN TAB 100MG | 100 MG | TABLET | ORGANON CANADA LTD LTEE | CANCELLED POST MARKET | 00593354 |
| FROBEN TAB 50MG | 50 MG | TABLET | ORGANON CANADA LTD LTEE | CANCELLED POST MARKET | 00593346 |
2 · Same class — other molecules in ATC M01AE
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Ibuprofen | ACTIPROFEN - CAPLET 200MG · ADVIL 12 HOUR · ADVIL ARTHRITIS PAIN · ADVIL CAPLETS · +107 more | 143 | 46 | Yes |
| Naproxen | ALEVE BACK AND BODY PAIN · ALEVE CAPLETS · ALEVE LIQUID GELS · ALEVE NIGHTTIME · +81 more | 125 | 31 | Yes |
| Ibuprofen, Combinations | ADVIL COLD & FLU · ADVIL COLD & SINUS CONVENIENCE PACK · ADVIL COLD & SINUS EXTRA STRENGTH LIQUI-GELS · ADVIL COLD & SINUS LIQUI-GELS · +36 more | 40 | 13 | Yes |
| Naproxen And Esomeprazole | MYLAN-NAPROXEN/ESOMEPRAZOLE MR · VIMOVO | 4 | 4 | Yes |
| Ketoprofen | KETOPROFEN · KETOPROFEN SR · KETOPROFEN SUPPOSITORIES · KETOPROFEN-E · +28 more | 36 | 3 | Yes |
| Tiaprofenic Acid | ALBERT TIAFEN SR · ALBERT TIAFEN TAB 200MG · ALBERT TIAFEN TAB 300MG · APO-TIAPROFENIC TABLETS -300MG · +15 more | 25 | 2 | Yes |
| Flurbiprofen | ANSAID TABLETS 100 MG · ANSAID TABLETS 50 MG · FLURBIPROFEN · FLURBIPROFEN-100 TAB 100MG · +12 more | 19 | 2 | Yes |
| Oxaprozin | APO-OXAPROZIN · DAYPRO · RHOXAL-OXAPROZIN | 3 | 0 | Not in Canada |
| Fenoprofen | NALFON CAP 300MG · NALFON TAB 600MG | 2 | 0 | Not in Canada |
| Naproxen And Diphenhydramine | PAIN RELIEVER & SLEEP AID | 1 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC M01A
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| M01AB | Diclofenac · Diclofenac, Combinations · Etodolac · Indometacin · Ketorolac · +2 more | 170 | 38 |
| M01AH | Celecoxib · Rofecoxib | 72 | 30 |
| M01AC | Meloxicam · Piroxicam · Tenoxicam | 67 | 14 |
| M01AG | Mefenamic Acid | 7 | 1 |
| M01AX | Nabumetone | 12 | 1 |
| M01AA | Oxyphenbutazone · Phenylbutazone · Phenylbutazone, Combinations | 7 | 0 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is ANSAID TABLETS 100 MG called?
The same molecule, Flurbiprofen, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Transact | Latin | South Africa |
| STREPSILS INTENSIVE | Latin | South Africa |
| Strepsils Intensive Spray | Latin | South Africa |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.